Goal 2: Reduce Human Disease

Funding for Hemostasis & Thrombosis Research

Thrombotic disorders, a result of the inappropriate activation of the hemostatic system, remain major causes of morbidity and mortality in the United States. Cancer, cardiovascular disease, trauma, and many of the other causes of death in the U.S. frequently culminate in a fatal thrombotic event. Notably, thromboembolic disease affects 500,000 people annually and leads to 100,000 deaths in the United States alone. Current estimates are that venous thromboembolisms cost the U.S. health system more than $1.5 billion each year. Despite this enormous burden to our nation’s health, these disorders are vastly and disproportionately under-resourced.

Tags (Keywords associated with the idea)


128 net votes
136 up votes
8 down votes
Idea No. 796